News
The FDA's breakthrough devices program helps the industry with faster review times, but the benefit to patients is unclear.
As devices come onto the market that have to follow the new FDA guidance of SBOMs and patching, backdoors may become easier ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results